4.5 Article

Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration

Journal

JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 39, Issue 9, Pages 934-944

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2020.05.006

Keywords

lung transplantation; gastroesophageal reflux disease; inflammation; bile acid; biomarkers

Funding

  1. National Institutes of Health/National Institute of Allergy and Infectious Diseases, Clinical Trials in Organ Transplantation Ancillary Study Fund
  2. Comprehensive Research Experience for Medical Students Research Scholar Program

Ask authors/readers for more resources

BACKGROUND: Gastroesophageal reflux disease (GERD) is a risk factor for chronic lung allograft dysfunction. Bile acids-putative markers of gastric microaspiration-and inflammatory proteins in the bronchoalveolar lavage (BAL) have been associated with chronic lung allograft dysfunction, but their relationship with GERD remains unclear. Although GERD is thought to drive chronic microaspiration, the selection of patients for anti-reflux surgery lacks precision. This multicenter study aimed to test the association of BAL bile acids with GERD, lung inflammation, allograft function, and anti-reflux surgery. METHODS: We analyzed BAL obtained during the first post-transplant year from a retrospective cohort of patients with and without GERD, as well as BAL obtained before and after Nissen fundoplication anti-reflux surgery from a separate cohort. Levels of taurocholic acid (TCA), glycocholic acid, and cholic acid were measured using mass spectrometry. Protein markers of inflammation and injury were measured using multiplex assay and enzyme-linked immunosorbent assay. RESULTS: At 3 months after transplantation, TCA, IL-1 beta, IL-12p70, and CCL5 were higher in the BAL of patients with GERD than in that of no-GERD controls. Elevated TCA and glycocholic acid were associated with concurrent acute lung allograft dysfunction and inflammatory proteins. The BAL obtained after anti-reflux surgery contained reduced TCA and inflammatory proteins compared with that obtained before anti-reflux surgery. CONCLUSIONS: Targeted monitoring of TCA and selected inflammatory proteins may be useful in lung transplant recipients with suspected reflux and microaspiration to support diagnosis and guide therapy. Patients with elevated biomarker levels may benefit most from anti-reflux surgery to reduce microaspiration and allograft inflammation. (C) 2020 International Society for Heart and Lung Transplantation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Reflux Surgery in Lung Transplantation: A Multicenter Retrospective Study

Cynthia L. Green, Brian C. Gulack, Shaf Keshavjee, Lianne G. Singer, Kenneth McCurry, Marie M. Budev, Tammy L. Reece, Anne O. Lidor, Scott M. Palmer, R. Duane Davis

Summary: A multicenter retrospective study found limited benefits of fundoplication for preventing bronchiolitis obliterans syndrome and improving survival compared to reflux disease without surgery after lung transplantation. However, the study had limitations in terms of sample size, follow-up duration, and potential selection bias, highlighting the need for a randomized, prospective study.

ANNALS OF THORACIC SURGERY (2023)

Article Surgery

Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document

Carmen Lefaucheur, Kevin Louis, Anna B. Morris, Jean-Luc Taupin, Peter Nickerson, Anat R. Tambur, Howard M. Gebel, Elaine F. Reed

Summary: This consensus report provides clinical practice recommendations in kidney, heart, lung, and liver transplantation based on expert assessment of quality and strength of evidence regarding the relationship between anti-HLA donor-specific antibodies and transplant outcome. The recommendations address major clinical problems in transplantation, including the clinical implications of positive posttransplant DSA detection, the relevance of posttransplant DSA assessment for diagnosis and treatment management, and the relevance of posttransplant DSA for allograft prognosis and risk stratification.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Critical Care Medicine

Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation

Aparna C. Swaminathan, Alec McConnell, Sarah Peskoe, Mustafa R. Bashir, Erika Bush Buckley, Courtney W. Frankel, Daniel J. Turner, Patrick J. Smith, Lorenzo Zaf, Lianne G. Singer, Laurie D. Snyder

Summary: This study investigated the relationship between multiple frailty models before lung transplantation and short-term outcomes after surgery. It found that cumulative deficit models of frailty were associated with outcomes within the first 90 days, while phenotypic frailty was associated with 1-year survival.

CHEST (2023)

Correction Cardiac & Cardiovascular Systems

Survival difference between high-risk and low-risk CFTR genotypes after lung transplant (vol 41, pg 1511, 2022)

Emily S. Clausen, Jeremy M. Weber, Megan L. Neely, Kathleen J. Ramos, Laurie D. Snyder

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study

Jamie L. Todd, Jeremy M. Weber, Francine L. Kelly, Megan L. Neely, Andrew Nagler, Dylan Carmack, Courtney W. Frankel, David M. Brass, John A. Belperio, Marie M. Budev, Matthew G. Hartwig, Tereza Martinu, John M. Reynolds, Pali D. Shah, Lianne G. Singer, Laurie D. Snyder, S. Sam Weigt, Scott M. Palmer

Summary: This study found an association between reduced levels of club cell secretory protein (CCSP) in bronchoalveolar lavage fluid (BALF) and the development of chronic lung allograft dysfunction (CLAD) in lung transplant recipients. Decreased CCSP in early post-transplant BALF may indicate an increased risk of later CLAD.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction

Liran Levy, Sajad Moshkelgosha, Ella Huszti, Sarah Hunter, Benjamin Renaud-Picard, Gregory Berra, Mitsuaki Kawashima, Juan Fernandez-Castillo, Eyal Fuchs, Milagros Dianti, Rasheed Ghany, Shaf Keshavjee, Lianne G. Singer, Jussi Tikkanen, Tereza Martinu

Summary: This study found that markers of epithelial activity and injury in bronchoalveolar lavage fluid (BAL) are associated with the diagnosis of chronic lung allograft dysfunction (CLAD) and different phenotypes of CLAD. The abnormal expression of airway mucins and epithelial cell death may be involved in the pathogenesis of CLAD, and their detection could assist in the development of targeted therapies.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Virology

Evaluation of host cellular responses to Epstein-Barr virus (EBV) in adult lung transplant patients with EBV-associated diseases

Lorenzo Zaffiri, Joshua E. Messinger, Erika J. Bush, Janet S. Staats, Prekshaben Patel, Scott M. Palmer, Kent J. Weinhold, Laurie D. Snyder, Micah A. Luftig

Summary: Reactivation of Epstein-Barr virus (EBV) is often seen in lung transplant recipients (LTRs), but the cellular immune responses to EBV in adult LTRs have not been fully described. In this study, we found significant changes in CD4/CD8 ratio, EBV-specific CD8(+)CD69(+) T cell responses, and NK cell phenotypic changes in adult LTRs with EBV-associated diseases. These findings provide valuable insights into the immune responses to EBV in adult LTRs and may contribute to improved management of EBV-related complications.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Medicine, Research & Experimental

JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunction

Aaditya Khatri, Jamie L. . Todd, Fran L. . Kelly, Andrew Nagler, Zhicheng Ji, Vaibhav Jain, Simon G. Gregory, Kent J. Weinhold, Scott M. Palmer

Summary: Chronic lung allograft dysfunction (CLAD), characterized by decline in pulmonary function and bronchiolitis obliterans, lacks approved therapies. Single-cell RNA-Seq and spatial transcriptomic analysis identified the important role of JAK-STAT signaling in airway epithelial cells in CLAD. Activation of JAK-STAT signaling leads to upregulation of MHC-I in airway basal cells, resulting in cytotoxic T cell-mediated basal cell death. This study provides mechanistic insight and potential therapeutic strategy for CLAD.

JCI INSIGHT (2023)

Article Critical Care Medicine

External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources

Aparna C. Swaminathan, Laurie D. Snyder, Hwanhee Hong, Susanna R. Stevens, Alexander S. Long, Eric Yanchenko, Ying Qiu, Rong Liu, Hongtao Zhang, Aryeh Fischer, Leah Burns, Lisa M. Wruck, Scott M. Palmer

Summary: This study aimed to develop IPF ECs using fit-for-purpose data standards and evaluate their endpoint comparability with the BMS-986020 phase II RCT. The results showed that IPF ECs generated from historical RCT placebo arms had comparable primary treatment effects to that of the original clinical trial, while ECs from real-world data sources did not.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Multidisciplinary Sciences

A machine-learning approach to human ex vivo lung perfusion predicts transplantation outcomes and promotes organ utilization

Andrew T. Sage, Laura L. Donahoe, Alaa A. Shamandy, S. Hossein Mousavi, Bonnie T. Chao, Xuanzi Zhou, Jerome Valero, Sharaniyaa Balachandran, Aadil Ali, Tereza Martinu, George Tomlinson, Lorenzo Del Sorbo, Jonathan C. Yeung, Mingyao Liu, Marcelo Cypel, Bo Wang, Shaf Keshavjee

Summary: In this study, authors developed a machine learning model called InsighTx, which accurately predicts transplant outcomes and increases organ utilization rates. Training and test datasets showed that InsighTx model achieved a high AUROC in predicting transplant outcomes. Implementation study also demonstrated that InsighTx increased the likelihood of transplanting suitable donor lungs and decreased the likelihood of transplanting unsuitable donor lungs.

NATURE COMMUNICATIONS (2023)

Article Critical Care Medicine

Voxelotor as a Treatment of Persistent Hypoxia in the ICU

Omar Al-Qudsi, John M. Reynolds, John C. Haney, Ian J. Welsby

Summary: Hypoxia is a common issue in the ICU, occurring due to various pathological characteristics. The oxygen-hemoglobin dissociation curve explains the affinity between hemoglobin and PO2, as well as factors affecting oxygen uptake and release. Limited research exists on manipulating the hemoglobin-oxygen relationship. Voxelotor, a hemoglobin oxygen-affinity modulator approved by the FDA, was used to assist with chronic hypoxia and weaning off mechanical support in two non-sickle cell disease patients.

CHEST (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Defining the Temporal Relationship Between Peak Lung Function and Quality of Life Trajectories after Lung Transplantation in a Large Multi-Center Cohort

W. M. Tsuang, Ml Neely, S. M. Palmer, LG. Singer, M. Budev, P. Shah, J. A. Belperio, J. M. Reynolds, L. D. Snyder

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Pharmacology & Pharmacy

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis

Joao A. de Andrade, Megan L. Neely, Anne S. Hellkamp, Daniel A. Culver, Hyun J. Kim, Timothy Liesching, Leonard J. Lobo, Murali Ramaswamy, Zeenat Safdar, Shaun Bender, Craig S. Conoscenti, Thomas B. Leonard, Scott M. Palmer, Laurie D. Snyder

Summary: This study investigated the impact of antifibrotic therapy on mortality and other outcomes in patients with idiopathic pulmonary fibrosis (IPF) using causal inference methodology. The results suggest that patients with IPF who receive antifibrotic therapy have improved survival but may also have increased risks of respiratory-related hospitalizations and acute worsening of IPF.

CLINICAL THERAPEUTICS (2023)

Article Respiratory System

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

Todd L. L. Astor, Hilary J. J. Goldberg, Laurie D. D. Snyder, Andrew Courtwright, Ramsey Hachem, Tahuanty Pena, Lorenzo Zaffiri, Gerard J. J. Criner, Marie M. M. Budev, Tany Thaniyavarn, Thomas B. B. Leonard, Shaun Bender, Aliaa Barakat, Janis L. L. Breeze, Peter LaCamera

Summary: In patients with idiopathic pulmonary fibrosis, discontinuing anti-fibrotic therapy < 5 medication half-lives before lung transplant may increase the risk of anastomotic and sternal dehiscence, while there were no differences in other intra-operative and post-transplant complications based on the timing of discontinuation of anti-fibrotic therapy.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2023)

No Data Available